نتائج البحث - "Collins, G.P."

1

Academic Journal

Predicting survival for chimeric antigen receptor T-cell therapy: a validation of survival models using follow-up data from ZUMA-1

المؤلفون: Vadgama, S., Mann, J., Bashir, Z., Spooner, C., Collins, G.P., Bullement, A.

وصف الملف: text

Relation: https://eprints.whiterose.ac.uk/184933/1/1-s2.0-S1098301521031818-main.pdf; Vadgama, S., Mann, J., Bashir, Z. et al. (3 more authors) (2022) Predicting survival for chimeric antigen receptor T-cell therapy: a validation of survival models using follow-up data from ZUMA-1. Value in Health, 25 (6). pp. 1010-1017. ISSN 1098-3015

الاتاحة: https://eprints.whiterose.ac.uk/184933/
https://eprints.whiterose.ac.uk/184933/1/1-s2.0-S1098301521031818-main.pdf

View record in BASE

2

Conference

Predicting COVID-19 infection risk in lymphoma by immune monitoring

المؤلفون: Wijaya, R., Campbell, N., Johnson, M., Stuart, B., Kelly, A., Tipler, N., Coleman, A., Turaj, A., Menne, T., Ahearne, M., Willimott, V., Al-Naeeb, A. Bowzyk, Fox, C.P., Collins, G.P., O'Callaghan, A., Davies, A.J., Goldblatt, D., Lim, S.H.

Relation: Wijaya, R., Campbell, N., Johnson, M., Stuart, B., Kelly, A., Tipler, N., Coleman, A., Turaj, A., Menne, T., Ahearne, M., Willimott, V., Al-Naeeb, A. Bowzyk, Fox, C.P., Collins, G.P., O'Callaghan, A., Davies, A.J., Goldblatt, D. and Lim, S.H. (2023) Predicting COVID-19 infection risk in lymphoma by immune monitoring. Hematological Oncology, 41 (S2), 606-607. (doi:10.1002/hon.3164_456 ).

الاتاحة: https://eprints.soton.ac.uk/494001/

View record in BASE

3

Academic Journal

PF721 MINIMAL CLINICALLY IMPORTANT DIFFERENCE AND RESPONSIVENESS FOR HM‐PRO IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

المؤلفون: Goswami, P., Ionova, T., Oliva, E.N., Else, R., Kell, J., Fielding, A.K., Jennings, D.M., Karakantza, M., Al‐Ismail, S., Collins, G.P., McConnell, S., Langton, C., Salek, S.

المصدر: HemaSphere ; volume 3, issue S1, page 315-316 ; ISSN 2572-9241 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000561168.46160.37
https://onlinelibrary.wiley.com/doi/pdf/10.1097/01.HS9.0000561168.46160.37

View record in BASE

4

Academic Journal

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.

وصف الملف: text

Relation: https://eprints.whiterose.ac.uk/130481/1/CHEMO%20T%20published%20manuscript.pdf; Gleeson, M., Peckitt, C., To, Y.M. et al. (25 more authors) (2018) CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematology , 5 (5). e190-e200. ISSN 2352-3026

الاتاحة: https://eprints.whiterose.ac.uk/130481/
https://eprints.whiterose.ac.uk/130481/1/CHEMO%20T%20published%20manuscript.pdf
https://doi.org/10.1016/S2352-3026(18)30039-5

View record in BASE

5

Academic Journal

BLOCKADE OF THE PD‐1 CHECKPOINT WITH ANTI–PD‐L1 ANTIBODY AVELUMAB IS SUFFICIENT FOR CLINICAL ACTIVITY IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (CHL)

المؤلفون: Chen, R., Gibb, A.L., Collins, G.P., Popat, R., El‐Sharkawi, D., Burton, C., Lewis, D., Miall, F.M., Forgie, A., Compagnoni, A., Andreola, G., Brar, S., Thall, A., Woolfson, A., Radford, J.

المصدر: Hematological Oncology ; volume 35, issue S2, page 67-67 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2437_54
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2437_54
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2437_54

View record in BASE

6

Academic Journal

THE ROLE OF 18F FDG‐PET/CT IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NCRI MULTICENTRE PHASE II RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY

المؤلفون: Gleeson, M., Peckitt, C., Cunningham, D., To, Y.M., Edwards, L., Chau, I., Johnson, P., Ardeshna, K.M., Wotherspoon, A., Attygalle, A., Begum, R., Zerizer, I., Hawkes, E.A., Macheta, M.P., Collins, G.P., Radford, J.A., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., Chua, S.

المصدر: Hematological Oncology ; volume 35, issue S2, page 244-245 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2438_108
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2438_108
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2438_108

View record in BASE

7

Academic Journal

RESULTS OF a MULTICENTRE UK‐WIDE STUDY EVALUATING THE EFFICACY OF BRENTUXIMAB VEDOTIN IN RELAPSED, REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN THE PRE‐TRANSPLANT NAÏVE SETTING

المؤلفون: Eyre, T.A., Phillips, E.H., Linton, K.M., Kassam, S., Gibb, A., Allibone, S., Peggs, K., Burton, C., Stewart, G., Ledieu, R., Booth, C., Osborne, W., Miall, F., Eyre, D.W., Ardeshna, K., Collins, G.P.

المصدر: Hematological Oncology ; volume 35, issue S2, page 82-83 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2437_70
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2437_70
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2437_70

View record in BASE

8

Academic Journal

PHASE 1/2A CLINICAL TRIALS OF BI‐1206, A MONOCLONAL ANTIBODY TO FCΓRIIB, ADMINISTERED AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH B‐CELL MALIGNANCIES

المؤلفون: Karlsson, I., Traub, S., Järås, K., Edwards, D., Gramming, E., Lindell Andersson, M., To, Y., Mårtensson, L., Teige, I., Acton, G., Dyer, M.J., Radford, J., Collins, G.P., Jerkeman, M., Frendéus, B., McAllister, A., Davies, A.

المصدر: Hematological Oncology ; volume 37, issue S2, page 520-521 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.206_2631
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.206_2631
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.206_2631

View record in BASE

9

Academic Journal

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL

المؤلفون: Fanale, M., Engert, A., Younes, A., Armand, P., Ansell, S., Zinzani, P.L., Timmerman, J.M., Collins, G.P., Ramchandren, R., Cohen, J.B., De Boer, J.P., Kuruvilla, J., Savage, K.J., Trneny, M., Rodig, S., Shipp, M., Kato, K., Sumbul, A., Farsaci, B., Santoro, A.

المصدر: Hematological Oncology ; volume 35, issue S2, page 135-136 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2437_124
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2437_124
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2437_124

View record in BASE

10

Academic Journal

IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN

المؤلفون: Hiddemann, W., Barbui, A.M., Canales Albendea, M.A., Cannell, P.K., Collins, G.P., Dürig, J., Forstpointner, R., Herold, M., Hertzberg, M., Klanova, M., Radford, J.A., Tobinai, K., Burciu, A., Fingerle‐Rowson, G.R., Nielsen, T., Wolbers, M., Marcus, R.

المصدر: Hematological Oncology ; volume 35, issue S2, page 117-119 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2437_106
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2437_106
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2437_106

View record in BASE

11

Academic Journal

Safety and efficacy of single‐agent ibrutinib in patients with relapsed/refractory ( R/R) marginal zone lymphoma ( MZL): A multicenter, open‐label, phase 2 study

المؤلفون: Collins, G.P., Noy, A., de Vos, S., Thieblemont, C., Martin, P., Flowers, C., Morschhauser, F., Ma, S., Coleman, M., Peles, S., Smith, S., Barrientos, J., Smith, A., Munneke, B., Dimery, I., Beaupre, D., Chen, R.

المصدر: Hematological Oncology ; volume 35, issue S2, page 211-212 ; ISSN 0278-0232 1099-1069

الاتاحة: http://dx.doi.org/10.1002/hon.2438_76
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2438_76
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2438_76

View record in BASE

12

Conference

Phase II Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

المؤلفون: Linton, K., Collins, G.P., Eyre, T.A., Radford, J., Soilleux, E., Hatton, C.S.

المصدر: Linton , K , Collins , G P , Eyre , T A , Radford , J , Soilleux , E & Hatton , C S 2014 , ' Phase II Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma ' , American Society of Hematology Annual Conference , New Orleans , 1/01/24 .

Relation: https://research.manchester.ac.uk/en/publications/3e827a6d-b1fb-4c62-a38f-1ff23500fe92

الاتاحة: https://research.manchester.ac.uk/en/publications/3e827a6d-b1fb-4c62-a38f-1ff23500fe92

View record in BASE

13

Academic Journal

The British and Foreign School Society Archives Centre

المؤلفون: Bartle, G.F., Collins, G.P.

المصدر: History of Education ; volume 10, issue 3, page 179-181 ; ISSN 0046-760X 1464-5130

الاتاحة: https://doi.org/10.1080/0046760810100302
http://www.tandfonline.com/doi/pdf/10.1080/0046760810100302

View record in BASE

14

Academic Journal

Prices received by Oklahoma farmers 1910-1957; monthly and annual prices of farm products and a revised series of price indexes

المؤلفون: Collins, G.P., Hill, W.G., Oklahoma State University. Dept. of Agricultural Economics., Oklahoma Agricultural Experiment Station., United States. Agricultural Estimates Division.

مصطلحات موضوعية: Agricultural prices

وصف الملف: ren

Relation: http://hdl.handle.net/2027/coo.31924013879618

الاتاحة: http://hdl.handle.net/2027/coo.31924013879618

View record in BASE

15

Academic Journal

Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.

المؤلفون: Malladi, R.K., Peniket, A.J., Norton, A.E., Campbell, A.J., Collins, G.P., Samol, J., Eagleton, H., Miller, E., Morgenstern, G., Jones, J., Keen-Mcguire, A., Barnardo, M., Littlewood, T.J.

المصدر: European Journal of Haematology; Aug2004, Vol. 73 Issue 2, p85-92, 8p

مصطلحات موضوعية: MYELODYSPLASTIC syndromes, STEM cell transplantation, CELL transplantation, TRANSPLANTATION of organs, tissues, etc., IMMUNOGLOBULINS, LEUKEMIA

16

Academic Journal

Making stars to see stars: DOD adaptive optics work is declassified. (cover story)

المؤلفون: Collins, G.P.

المصدر: Physics Today. Feb92, Vol. 45 Issue 2, p17. 5p. 3 Color Photographs, 1 Diagram.

مصطلحات موضوعية: *OPTICS

17

Academic Journal

CHOP VERSUS GEM-P IN THE FIRST-LINE TREATMENT OF T-CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO-T TRIAL.

المؤلفون: Gleeson, M., Peckitt, C., To, Y.M., Edwards, L., Chau, I., Johnson, P., Ardeshna, K.M., Wotherspoon, A., Attygalle, A., Begum, R., Chua, S., Zerizer, I., Hawkes, E.A., Macheta, M.P., Collins, G.P., Radford, J.A., Forbes, A., Hart, A., Montoto, S., McKay, P.

المصدر: Hematological Oncology; Jun2017 Supplement, Vol. 35, p75-76, 2p

18

Academic Journal

AIP Corporate Associates hold 1991 meeting at Grumman Corporation.

المؤلفون: Collins, G.P.

المصدر: Physics Today. Jan92, Vol. 45 Issue 1, p59. 2p. 2 Black and White Photographs.

مصطلحات موضوعية: *PHYSICS

19

Academic Journal

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study

المؤلفون: Ansell S. M., Brockelmann P. J., von Keudell G., Lee H. J., Santoro A., Zinzani P. L., Collins G. P., Cohen J. B., de Boer J. P., Kuruvilla J., Savage K. J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M. A., Engert A., Armand P.

المساهمون: Ansell S.M., Brockelmann P.J., von Keudell G., Lee H.J., Santoro A., Zinzani P.L., Collins G.P., Cohen J.B., de Boer J.P., Kuruvilla J., Savage K.J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M.A., Engert A., Armand P.

مصطلحات موضوعية: Nivolumab, relapsed/refractory, Hodgkin lymphoma, 5-year survival, CheckMate 205 study

وصف الملف: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/37530622; info:eu-repo/semantics/altIdentifier/wos/WOS:001097076600001; volume:7; issue:20; firstpage:6266; lastpage:6274; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960011; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85175416545; https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classical

الاتاحة: https://hdl.handle.net/11585/960011
https://doi.org/10.1182/bloodadvances.2023010334
https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classical

View record in BASE

20

Academic Journal

Avelumab in relapsed/refractory classical hodgkin lymphoma: Phase 1b results from the JAVELIN hodgkins trial

المؤلفون: Herrera A. F., Burton C., Radford J., Miall F., Townsend W., Santoro A., Zinzani P. L., Lewis D., Fowst C., Brar S., Huang B., Thall A., Collins G. P.

المساهمون: Herrera A.F., Burton C., Radford J., Miall F., Townsend W., Santoro A., Zinzani P.L., Lewis D., Fowst C., Brar S., Huang B., Thall A., Collins G.P.

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Human, Neoplasm Recurrence, Local, Tumor Microenvironment, Hodgkin Disease

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000702743800015; volume:5; issue:17; firstpage:3387; lastpage:3396; numberofpages:10; journal:BLOOD ADVANCES; http://hdl.handle.net/11585/866835; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85115422314; https://ashpublications.org/bloodadvances/article/5/17/3387/476711/Avelumab-in-relapsed-refractory-classical-Hodgkin

الاتاحة: http://hdl.handle.net/11585/866835
https://doi.org/10.1182/BLOODADVANCES.2021004511
https://ashpublications.org/bloodadvances/article/5/17/3387/476711/Avelumab-in-relapsed-refractory-classical-Hodgkin

View record in BASE

تنقيح النتائج